Holder snapshot 7 signals
Share change
-23,199,032
Put/Call ratio
111%
SEC-reported price per share
$8.01
Indexed holders
404
Value change
-$275,589,149
Number of buys
158
Open additional details 1 more signal available
Number of sells
178
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,166,523,868

Security key

881624209

Report period

Q4 2021

Indexed institutions

404

Top holders

10

Ownership snapshot

Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F Highest disclosed value: $1,157,902,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors has the largest disclosed position value at $1.16B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.
Disclosed position value Top 5
Capital Research Global Investors $1.16B
BERKSHIRE HATHAWAY INC $416.77M
BlackRock Finance, Inc. $394.88M
ABRAMS CAPITAL MANAGEMENT, L.P. $234.21M
Migdal Insurance & Financial Hold... $207.32M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capital Research Global Investors
13F
Company
13F
—
denominator unverified
$1,157,902,000
118,876,651 shares
— 30 Sep 2021
BERKSHIRE HATHAWAY INC
13F
Company
13F
—
denominator unverified
$416,768,000
42,789,295 shares
— 30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$394,877,000
40,541,845 shares
— 30 Sep 2021
ABRAMS CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$234,212,000
24,046,356 shares
— 30 Sep 2021
Migdal Insurance & Financial Holdings Ltd.
13F
Company
13F
—
denominator unverified
$207,317,000
21,284,555 shares
— 30 Sep 2021
MENORA MIVTACHIM HOLDINGS LTD.
13F
Company
13F
—
denominator unverified
$190,558,000
19,564,520 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
404
Shares
505,268,193
Indexed holders
404
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 indexed holders
408
Q4 2021 indexed holders
404
Indexed holder difference
-4
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .